학술논문
Predictive and pharmacodynamic biomarkers associated with phase II, selective and orally bioavailable AXL inhibitor bemcentinib across multiple clinical trials
Document Type
Article
Author
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology . (Annals of oncology : official journal of the European Society for Medical Oncology, 1 October 2018, 29:viii19)
Subject
Language
English
ISSN
15698041